According to the research report titled ‘Global Neurointerventional Devices Market Size study, by Type (Neurovascular Thrombectomy Devices, Neurovascular Stents, Embolic Protection Devices, Intrasaccular Devices, Embolic Coils, Flow Diverters, Liquid Embolics, Balloons, and Stent Retrievers); Technique (Neurothrombectomy, Stenting, Coiling Procedure, Cerebral Angiography, Flow Disruption); End User (Hospitals, Ambulatory Surgical Centers) and Regional Forecasts 2020-2027’, available with Market Study Report, global neurointerventional devices market was worth USD 2.5 billion in 2019 and is predicted to grow at a 8% CAGR during 2020-2027, subsequently reaching a valuation of USD 4.6 billion by the end of the forecast period.
 

As per the report findings, factors such as growing target patient population, attractive medical reimbursements, and escalating consumer demand for advanced neurovascular products are augmenting global neurointerventional devices market size. Further, healthcare infrastructural development in developing nations, and innovative product launches are adding considerable traction to the industry growth.
 

For those unaware, neurointerventional radiology, also known as neurovascular surgery, is a medical specialty treatment that uses minimally invasive endovascular techniques for treating vascular brain diseases. Of late, this procedure has been gaining significant popularity among neuro-specialists, owing to decreased invasiveness.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3029639/
 

On the contrary, lack of skilled professionals, and imposition of stringent regulations will continue to barricade business development during the analysis timeframe.
 

Based on type, global neurointerventional devices market is fragmented into embolic protection devices, balloons, stent retrievers, liquid embolics, embolic coils, flow diverters, intrasaccular devices, and neurovascular thrombectomy devices.
 

With regards to technique, the market is divided into coiling procedure, cerebral angiography, stenting, and flow disruption, neurothrombectomy.
 

Elaborating on the end-user landscape, the industry vertical is bifurcated into hospitals and ambulatory surgical centers.
 

Regionally speaking, North America currently dominates global neurointerventional devices market sphere and is anticipated to amass substantial gains during the study period. Rapid infrastructural development in healthcare sector and surging consumer demand for innovative neurovascular products with proven success are contributing to the regional industry remuneration.
 

On the other hand, Asia-Pacific industry is estimated to grow exponentially during 2020-2027, attributable to burgeoning patient population, attractive medical reimburse scenery, and increasing innovative product launches by major manufacturers.
 

Top organizations influencing the worldwide neurointerventional devices market trends are Stryker Corp., MicroPort Scientific Corp., Medtronic plc, iVascular S.L.U., InspireMD, Inc., Boston Scientific Corp., Terumo Corp., Merit Medical Systems, Inc., Rapid Medical Ltd., and Penumbra, Inc.